Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 1/20 | 0.33 |
| ▸ | FEN1 | P39748 | 1/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.30 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27034099 | 0.96 | ALOX5AP (0.35) | ALOX5APFEN1PIK3CDPIK3CGOPRM1 | |
| SCHEMBL30845924 | 0.96 | ALOX5AP (0.35) | ALOX5APFEN1PIK3CDPIK3CGOPRM1 | |
| SCHEMBL31416641 | 0.94 | ALOX5AP (0.33) | ALOX5APFEN1CYP11B2 | |
| SCHEMBL30719521 | 0.89 | HCRTR1 (0.32) | CYP11B2 | |
| SCHEMBL31416568 | 0.87 | ALOX5AP (0.32) | ALOX5APFEN1 | |
| SCHEMBL31416521 | 0.87 | LRRK2 (0.34) | OPRM1OPRL1 | |
| SCHEMBL27034210 | 0.87 | ALOX5AP (0.33) | ALOX5APFEN1OPRM1OPRL1 | |
| SCHEMBL30845913 | 0.86 | ALOX5AP (0.33) | ALOX5APFEN1OPRM1OPRL1 | |
| SCHEMBL27034112 | 0.86 | ALOX5AP (0.33) | ALOX5APFEN1OPRM1OPRL1 | |
| SCHEMBL31416687 | 0.85 | OPRM1 (0.34) | ALOX5APFEN1OPRM1OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025043148-A1 | EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF | BIOGEN MA INC. (US) | 2025-02-27 | — | — | WO | claimed |
| WO-2025043148-A1 | EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF | BIOGEN MA INC. (US) | 2025-02-27 | — | — | WO | disclosed |